Fisher & Paykel Healthcare Co. Limited (ASX:FPH) Insider Graham McLean Acquires 1,000 Shares

Fisher & Paykel Healthcare Co. Limited (ASX:FPH) insider Graham McLean acquired 1,000 shares of the business’s stock in a transaction on Monday, February 17th. The stock was acquired at an average cost of A$32.30 ($20.71) per share, with a total value of A$32,300.00 ($20,705.13).

Fisher & Paykel Healthcare Stock Performance

The company has a current ratio of 1.83, a quick ratio of 0.79 and a debt-to-equity ratio of 10.75. The firm has a market capitalization of $20.55 billion, a price-to-earnings ratio of 157.79, a P/E/G ratio of 4.47 and a beta of 0.42.

Fisher & Paykel Healthcare Increases Dividend

The company also recently declared a Interim dividend, which was paid on Tuesday, December 17th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.167 per share. This represents a dividend yield of 0.49%. The ex-dividend date of this dividend was Wednesday, December 4th. This is an increase from Fisher & Paykel Healthcare’s previous Interim dividend of $0.17. Fisher & Paykel Healthcare’s dividend payout ratio is 180.95%.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.